Articles

Diabetes patients enrolled in a medical home program supported by multiple payers saw improvements in several aspects of their care.…

An investigational first in class compound with a novel mechanism of action appears to improve glycemic control in type 2 diabetes.…

Recent data suggest that treatment with metformin during late childhood or early puberty may impede or prevent the development of polycystic ovary syndrome in girls at high risk for the disease.…

Over the past few weeks we have been looking at your colleagues’ responses to questions about GLP-1, including mechanisms, interactions, dosing and effectiveness. Over the next two weeks we will examine some of your opinions on starting doses and selecting patients….

Oxyntomodulin is a gut peptide released in response to a meal. It is synthesized within specialized enteroendocrine cells called L cells. Oxyntomodulin is released from the intestinal L cells 5-10 minutes after ingestion of food in amounts proportional to calorie intake and levels peak 30 minutes after meals. Oxyntomodulins are …

Eli Lilly aims to bring its once-a-week diabetes injection Bydureon to US markets in the first half of next year.…

Eating nuts every day could help control Type 2 diabetes and prevent its complications.…

Canadian researchers were surprised when personalized computer-generated feedback mailed to type 2 diabetes patients didn’t help them improve their glycemic control.…

Researchers have shown that fisetin, a type of flavonoid found in strawberries and to a lesser extent in other foods, reduces neurologic complications and kidney damage in type 1 diabetes.…

Physical activity is a cornerstone of treatment for diabetes, yet people with diabetes perform less moderate and vigorous physical activity (MVPA) than people without diabetes.…